Short Interest in Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) Declines By 34.2%
Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 5,200 shares, a drop of 34.2% from the April 30th total of 7,900 shares. Based on an average daily trading volume, of 14,600 shares, the short-interest ratio is presently […]